Status:
COMPLETED
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Pfizer
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
2+ years
Brief Summary
Pilot study of flexible and wearable sensor to monitor nocturnal scratching behavior
Detailed Description
Present an advanced flexible, and wearable sensor intimately coupled to the skin that can measure the full spectrum of relevant physiological parameters associated with atopic dermatitis including scr...
Eligibility Criteria
Inclusion
- Participants with mild to moderate atopic dermatitis ages 2 years or older. This will be determined by clinical diagnosis of AD according to the Hanifin and Rajka criteria with a baseline Investigators Global Assessment score of mild (2) or moderate (3)
- Systemic therapy use (e.g. oral corticosteroid, cyclosporine, methotrexate, phototherapy) within 28 days of subject enrollment
- Topical corticosteroid use or topical calcineurin inhibitor use within 14 days of subject enrollment
- Willingness and ability to set up an infrared video camera nightly
- Willing to apply topical crisaborole twice daily to affected atopic dermatitis areas of the body
Exclusion
- Active skin or systemic infection
- Inability to operate a smartphone or video camera
- Active atopic dermatitis on he dorsum of the hand or suprasternal notch
Key Trial Info
Start Date :
April 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 24 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03770858
Start Date
April 18 2019
End Date
August 24 2022
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611